@ARTICLE{
author={Kazasidis Marios,Yin Shuo,Cassidy Jonathan,Volkov-Husovic Tatjana D,Vlahovic Milica M,Martinovic Sanja P,Kyriakopoulou Elena,Lupoi Rocco},
year={2020},
title={Microstructure and cavitation erosion performance of nickel-Inconel 718 composite coatings produced with cold spray},
journal={SURFACE & COATINGS TECHNOLOGY},
volume={382},
number={},
pages={-},
document_type={Article},
} 

@ARTICLE{
author={Cassidy Jonathan,Jelic Svetislav B,Pluzanska Anna,Ciuleanu Tudor-Eliade,Babu KG,Stewart John S,Schupp JPH},
year={2008},
title={Comparative Phase 2 Study of Infusional 5, 10-Methylenetetrahydrofolate with 5-Fluorouracil (Fu) Versus Leucovorin (Lv) with Fu In Patients with Metastatic Colorectal Cancer},
journal={ANNALS OF ONCOLOGY},
volume={19},
number={},
pages={130-130},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Cassidy Jonathan,Douillard Y,Twelves C,McKendrick JJ,Scheithauer W,Bustova I,Johnston PG,Lesniewski-Kmak L,Jelic Svetislav B,Fountzilas George,Coxon F,Diaz-Rubio E,Maughan TS,Malzyner A,Bertetto O,Beham A,Figer A,Dufour P,Patel KK,Cowell},
year={2006},
title={Pharmacoeconomic analysis of adjuvant oral capecitabine vs intravenous 5-FU/LV in Dukes' C colon cancer: the X-ACT trial},
journal={BRITISH JOURNAL OF CANCER},
volume={94},
number={8},
pages={1122-1129},
document_type={Article},
} 

@ARTICLE{
author={Nikolic-Tomasevic Zorica I,Jelic Svetislav B,Cassidy Jonathan,Filipovic-Ljeskovic Ivana M,Tomasevic Zoran M},
year={2005},
title={Fluoropyrimidine therapy: hyperbilirubinemia as a consequence of hemolysis},
journal={CANCER CHEMOTHERAPY AND PHARMACOLOGY},
volume={56},
number={6},
pages={594-602},
document_type={Article},
} 

@ARTICLE{
author={McKendrick JJ,Cassidy Jonathan,Chakrapee-Sirisuk S,Fountzilas George,Iveson T,Jelic Svetislav B,Kamicka-Mlodkowska H,Ostojic R,Scheithauer W,Twelves C},
year={2004},
title={Capecitabine (X) is resource saving compared with i.v. bolus 5-FU/LV in adjuvant chemotherapy for Dukes' C colon cancer patients: Medical resource utilization (MRU) data from a large phase III trial (X-ACT).},
journal={JOURNAL OF CLINICAL ONCOLOGY},
volume={22},
number={14},
pages={3578-},
document_type={Meeting Abstract},
}